Related Experiment Video
Updated: Jun 21, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Heart failure with preserved ejection fraction in older adults
1Division of Cardiology, Harborview Medical Center, University of Washington, Seattle, WA 98104, USA. michen@u.washington.edu
Older adults often develop heart failure with preserved ejection fraction (HFpEF), especially hypertensive women. Current HFpEF treatments lack strong evidence, but research offers future hope for better patient care.
Area of Science:
- Gerontology
- Cardiology
- Internal Medicine
Background:
- Aging leads to physiological changes increasing heart failure risk in older adults.
- Heart failure with preserved ejection fraction (HFpEF) is prevalent in elderly hypertensive women.
- Hypertension is a critical factor in the pathophysiology of HFpEF.
Purpose of the Study:
- To summarize the current understanding of HFpEF in older adults.
- To highlight the role of hypertension in HFpEF.
- To discuss the limited treatment basis for HFpEF and future research directions.
Main Methods:
- Review of existing literature on age-related heart failure.
- Analysis of pathophysiological mechanisms linking hypertension and HFpEF.
- Evaluation of current therapeutic strategies and evidence gaps.
Main Results:
- Age-related changes significantly contribute to HFpEF development.
- Hypertension is a key driver of HFpEF, particularly in older women.
- Established treatments for HFpEF are limited compared to heart failure with reduced ejection fraction.
Conclusions:
- HFpEF is a growing concern in the aging population, linked to hypertension.
- Effective treatment strategies for HFpEF remain an area of active investigation.
- Ongoing clinical studies are crucial for advancing HFpEF patient care.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management

